David S. Tierney - 08 Dec 2023 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Director
Signature
/s/ David S. Tierney
Issuer symbol
CPRX
Transactions as of
08 Dec 2023
Net transactions value
$0
Form type
4
Filing time
12 Dec 2023, 17:00:46 UTC
Previous filing
12 May 2023
Next filing
14 Dec 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Award $0 +29,524 +11% $0.000000 290,024 08 Dec 2023 Common Stock 29,524 $14.15 Direct F1
transaction CPRX Restricted Stock Units Award $0 +4,240 +1.5% $0.000000 294,264 08 Dec 2023 Common Stock 4,240 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Derivative securities vest in equal tranches, 1/3rd on December 8, 2024, 1/3rd on December 8, 2025 and 1/3rd on December 8, 2026.
F2 Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
F3 Shares of common stock will be delivered to the Reporting Person upon vesting.